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Abstract Fetal cells occur in maternal blood in a substantial 
proportion of normal pregnancies. Several different approaches 
have been used to detect and enrich these cells for non-invasive 
prenatal diagnosis. However, before these fetal cells can 
routinely be used for prenatal diagnosis, perfectly reproducible 
procedures for detection and enrichment need to be established. 
We found that these fetal cells express high intracellular levels of 
the DNA precursor pathway enzyme thymidine kinase. Since 
normal adult peripheral blood cells do not exhibit any thymidine 
kinase activity, this enzyme is a potent new marker to detect and 
enrich fetal cells from maternal blood. We further describe the 
first successful application of a cytofluorometric thymidine 
kinase assay to detect fetal cells in the maternal circulation by 
virtue of their high thymidine kinase activity. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Prenatal diagnosis is based on non-invasive techniques, 
such as ul trasound or maternal serum screening. For more 
detailed information invasive procedures are used to remove 
fetal tissue, which then can be analysed for chromosome 
anomalies, molecular genetic diseases or biochemical varia-
tions. All currently available methods for fetal tissue sam-
pling, such as amniocentesis, chorionic villus sampling or iso-
lation of fetal umbilical cord blood, carry procedure-related 
risks for the fetus. Since the first detection of fetal cells in the 
maternal circulation [1], a series of methods have been applied 
in attempts to detect and enrich them for use in non-invasive 
prenatal diagnosis [2-7]. Circulating cells of fetal origin in-
clude trophoblasts, fetal lymphocytes, nucleated red blood 
cells and hematopoetic stem cells [3]. Most of the investiga-
tions to quantify the circulating fetal cells used Y-chromo-
some sequence analysis in pregnancies with male fetuses. Dif-
ferent approaches for quantitative D N A analysis revealed that 
in first- and second-trimester pregnancies the fetal/maternal 
cell ratio varies between 1:475 000 and 1:1600000. Thus in 
any 10 ml blood sample between 200 and 60 fetal cells are 
present [8,9]. Each fetal cell type has already been investigated 
with respect to its enrichability from maternal circulation. The 
results thus obtained are very promising and indicate that 
non-invasive prenatal diagnosis via these cells is probably 
within reach. However, it is without doubt that detection 
and enrichment techniques will have to be improved before 
these fetal cells can be routinely used for prenatal diagnosis. 
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The major limiting factor is to find a very sensitive marker 
which is highly specific for fetal cells among the excess of 
adult cells. 
We report that fetal cells in the maternal circulation express 
high levels of the D N A precursor pathway enzyme thymidine 
kinase (TK). Since normal peripheral adult blood does not 
exhibit any T K activity, we show this activity to be useful 
as a specific marker for fetal cells. Using this marker we 
were able to cytofluorometrically detect fetal cells in the excess 
of maternal cells. Our results open a new and potent possibil-
ity to detect and enrich fetal cells from the maternal circula-
tion. 
2. Materials and methods 
2.1. Cells 
Samples from patients at different weeks of pregnancy undergoing 
amniocentesis, chorionic villus sampling, or isolation of fetal umbilical 
cord blood for standard obstetric indications were used for analysis. 
These cells were directly analysed without prior cultivation. Nucleated 
cells from peripheral blood samples (20 ml, collected in heparin) were 
obtained by densitiy gradient centrifugation on Ficoll-Paque. The 
blood was mixed with phosphate-buffered saline (PBS) in a tube at 
the bottom of which Ficoll-Paque was gently layered. After centrifu-
gation the cells at the interface between the plasma and red cells were 
collected and analysed. Permission to use parts of the obtained ma-
terials for the presented study was obtained from the institutional 
review board. Fetal and adult fibroblasts were obtained from the 
American Type Culture Collection. 
2.2. Radioactive thymidine kinase assay in cell extracts 
Thymidine kinase activity in vitro was measured by conversion of 
radioactive thymidine to thymidine monophosphate [10]. Enzyme ac-
tivities were normalized to total protein concentration, determined 
using the BioRad protein assay reagent with bovine serum albumin 
(BSA) as a standard. 
2.3. Cytofluorometric thymidine kinase assay 
Synthesis and purification of the fluorescent thymidine analogue 
AUdR/DANS were published previously, and cytofluorometric meas-
urement of TK activity in living cells was performed as described 
[11,12]. Cells were exposed in RPMI medium without serum for 30 
min to 1.5 mM AUdR/DANS (a stock solution was prepared in 70% 
ethanol) at 37°C and 7.5% C0 2 . After harvesting by centrifugation for 
5 min at 1000 rpm, cells were washed twice with PBS. The cells were 
resuspended in 100 mM Tris-HCl (pH 7.4), 154 mM NaCl, 1 mM 
CaCl2, 0.5 mM MgCl2, 0.1% NP-40 and 0.2% BSA (a 10X stock 
solution of BSA was stored at —20°C and it was thawed briefly before 
analysis) to a concentration of about 1 X 106 cells/ml. DNA staining 
was performed with 1.5 ug/ml ethidium bromide for 10 min on ice. 
Cells were analysed within the following 20 min to ensure that they 
were still alive and that the intracellular level of phosphorylated thyi-
midine analogue remained unchanged. TK activity and DNA content 
were simultaneously measured with a Partec PAS-II flow cytometer. 
Filters were set to obtain a complete separation of emission of the 
fluorescent analogue (500 nm) and of ethidium bromide (605 nm). 
2.4. Single-cell isolation and PCR analyses 
For single-cell isolation [13] cells were washed and diluted with 
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PBS. The cell supension was spotted in microdrops (0.1-0.2 ul) onto 
cleaned coverslips, that were previously coated with 0.1 (xl of endo-
nuclease-free BSA (0.1 mg/ml in 0.1 XPBS) to prevent cell adherence 
to the coverslip. The albumin-containing microdrops were allowed to 
dry before application of the cells. TK activity of the separated cells 
was determined under the microscope after incubation with the fluo-
rescent thymidine analogue AUdR/DANS as described in [14]. Micro-
drops containing only one live cell were flushed with 1 ul of PBS and 
pipetted into a microreaction tube containing 3.5 ul of lysis buffer. 
Microdrops containing no visible cells were picked as negative con-
trols. Lysis buffer was 0.68% Nonidet P-40, 0.68% Tween-20, 26.2 
mM Tris-HCl (pH 8.3), 75 mM KC1, 2.2 mM MgCl2 and 57 ug/ml 
proteinase K. The lysates were covered with a drop of mineral oil and 
incubated at 52°C for 30 min. Proteinase K was then heat-inactivated 
by incubating the tubes for 20 min at 95°C. After heat inactivation 
first-round PCR amplifications were performed in 10 ul reactions 
containing 5 pmol of each primer, and 0.5 mM of each deoxynucleo-
side triphosphate in 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 2 mM 
MgCl2, 0.005% (w/v) gelatin and 1 U of Taq polymerase. 
Y-chromosome-specific PCR was performed by a dual amplification 
procedure using the primers Y1.5 (5'-CTAGACCGCAGAGGCGC-
CAT-3') and Y1.6 (5'-TAGTACCCACGCCTGCTCCGG-3') in a 
first-round PCR. One microliter of the first-round product was ream-
plified by nested PCR with Y1.7 and Y1.8 (5'-CATCCAGA-
GCGTCCCTGGCTT-3' and 5'-CTTTCCACAGCCACATTTGTC-
3'). Each round consisted of 30 cycles of 94°C for 1 min, 60°C for 
30 s and 72°C for 2 min. We used two primers specific for sequences 
of the HERS oncogene as internal control (5'-GACAAA-
CACTGGTGCTGATC-3' and 5'-GCCCTTTTATTCTGAATCCG-
3', compare [15]). 
3. Results 
We have analysed different fetal and adult cell types for 
intracellular TK activity using a radioactive enzyme assay. 
Trophoblasts, amniotic cells, fetal and adult fibroblasts as 
well as fetal umbilical cord blood cells expressed TK enzyme 
activity, whereas adult peripheral blood did not exhibit meas-
urable activity (Fig. 1). Since TK activity is known to be S-
phase regulated (see e.g. [10]), we wondered whether these 
differences might be determined by different proliferation con-
ditions of these cells. However, flowcytometric analysis re-
vealed that the trophoblast samples, the amniotic cells, the 
fetal cord blood and the adult peripheral cell populations all 
contained between 90 and 95% GO or Gl cells with 2n DNA 
content (see Fig. 2). The fibroblasts exhibited a DNA distri-
bution typical for logarithmically growing cells (data not 
shown). Here it is important to note that the amniotic cells 
were analysed directly after the sampling procedure and not 
after growth cultivation. From chromosomal analyses we fur-
ther knew that the analysed trophoblast samples contained 
dividing cells. Therefore, the observed DNA distributions in-
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Fig. 1. TK activity in different cell extracts. Protein was extracted 
from different primary human cells and analysed for intracellular 
TK activity via the traditional radioactive TK assay. TK activity is 
given in picomoles TMP formed per miligram protein per hour. Re-
sults of three independent determinations are presented. The num-
bers given in brackets reflect the week of pregnancy at which the 
sample was isolated. 
dicate that only a few cells in the samples still divide or that 
the cells proliferate very slowly, reflected by a very long Gl 
phase. We confirmed the obtained data on DNA distributions 
by analysing the incorporation of radioactive thymidine into 
DNA. We did not observe significant levels of thymidine in-
corporation in any of these cells, except fibroblasts (data not 
shown). However, we could not really clarify whether the fetal 
cells express TK activity because they still divide very slowly 
or because TK activity is aberrantly expressed in the Go/Gl-
phase of the cell cycle. 
To further investigate this issue we performed simultaneous 
measurements of TK activity and DNA content of theses 
cells. We used a cytofluorometric assay, recently established 
in our laboratory, to detect transformed cells with high TK 
activity in an excess of normal cells with low activity 
Table 1 
TK-positive cells in the maternal circulation contain Y-chromosome DNA 
Patient Week of pregnancy FACS calculation of TK+ in T K - cells8 Single cell PCRb 
TK+/Y+ 
2/2 
2/2 
1/1 
2/2 
2/2 
3/3 
3/3 
TK- /Y+ 
6/0 
5/0 
8/0 
4/0 
8/0 
7/0 
8/0 
1 
2 
3 
4 
5 
6 
7 
10 
11 
12 
12 
13 
15 
19 
1:750000 
1:560000 
1:820000 
1:980000 
1:880000 
1:790000 
1:590000 
"The ratio of TK-positive cells (TK+) in TK-negative cells (TK—) in maternal peripheral blood was estimated on the flowcytometer as shown in 
Fig. 2. 
b Single cell PCR was performed as described in Section 2. TK+ and TK— cells isolated by a minimal dilution procedure were tested for Y-
chromosome DNA. Only those experiments with positive PCR signals using the control oligonucleotides for the oncogene HERS are presented. 
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[11,12,16,17]: The cells are incubated with the fluorescent thy-
midine analogue AUdR/DANS. Intracellular accumulation of 
this analogue reflects TK activity. The DNA of these cells is 
further stained with ethidium bromide. These two fluorescen-
ces are simultaneously detected on a flow cytometer (for de-
tails of the method see [11], and Section 2). By this method we 
detected TK activity in trophoblasts, amniotic cells and fetal 
cord blood cells (Fig. 2). Analysing peripheral blood cells 
(about 30 million per individual) of 24 non-pregnant women 
(without any previous pregnancy) and 13 male individuals, we 
could not detect TK-positive cells (Fig. 2, see also [17]). Strik-
ingly, using the same approach to analyse 14 pregnant women 
we observed a very small cell population with high TK activ-
ity (Fig. 2). For these analyses we chose women between 10 
and 21 weeks of pregnancy without any previous pregnancies. 
We did not observe significant qualitative or quantitative dif-
ferences in the cytofiuorometric detection of TK-positive cells 
in the patients at different stages of pregnancy (see some ex-
amples in Table 1). We estimated the cell numbers of these 
small TK-positive populations to be between 30 and 60 in 30 
million of total analysed cells. 
To prove that these cells with high TK activity, which we 
specifically detected in the circulation of pregnant women, 
were indeed of fetal origin, we chose the following experimen-
tal approach. We isolated nucleated cells from 20 ml of pe-
ripheral blood of a woman pregnant with a male fetus. We 
incubated these cells in a reaction tube with the fluorescent 
thymidine analogue AUdR/DANS as described for the cyto-
fiuorometric TK assay in Section 2. Next we divided these 
cells into smaller populations of about 100 cells and micro-
scopically analysed them for TK expression. Cell populations 
which contained one TK-positive cell, such as cell 1 in Fig. 
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Fig. 2. Simultaneous cytofiuorometric detection of DNA content 
and TK activity in living cells. About 8000 primary trophoblasts, 
amniotic cells, or fetal cord blood cells were cytofluorometrically an-
alysed as described in Section 2. In case of adult peripheral blood 
of non-pregnant and pregnant women about 30 million cells were 
analysed. A two-dimensional presentation of DNA content (abcissa) 
against TK activity (ordinate) is shown (not that increasing enzyme 
activity goes down the axis!). The numbers given in brackets reflect 
the week of pregnancy at which the sample was isolated. 
Fig. 3. Those cells in the maternal circulation with high TK activity 
are of fetal origin. A: Peripheral blood cells of a woman pregnant 
(11th week) with a male fetus were incubated with the fluorescent 
thymidine analogue AUdR/DANS and microscopically analysed for 
TK expression. Accumulation of the fluorescent analogue reflects in-
tracellular TK activity. B: DNA of a maternal peripheral blood cell 
population containing a TK-positive cell (cell 1) and of a popula-
tion not containing any TK-positive cells (cell 2) was extracted. The 
extracted DNA was analysed by PCR for Y-chromosome sequences 
and, as a control, for the HERS oncogene. 
3 A, were designated as cell type 1. Populations with no de-
tectable TK-positive cells were designated as cell type 2. We 
extracted DNA and analysed using PCR for the presence of 
Y-chromosome sequences. As an internal control of the ex-
perimental procedure we co-amplified sequences specific for 
the oncogene HERS. All 10 cell populations of type 1 thus 
obtained contained Y-chromosome DNA, whereas none of 
the 74 analysed type 2 cell populations contained any Y-chro-
mosome sequences (Fig. 3B). 
One might imagine that something special about pregnancy 
could cause the appearance of TK-positive adult cells only in 
pregnant women. Accordingly, we next wanted to exclude the 
possibility that some of the detected TK-positive cells are of 
maternal origin. Nucleated blood cells of seven women at 
different stages of pregnancy were incubated with AUdR/ 
DANS and microscopically analysed for TK expression (as 
shown in Fig. 3). We isolated single TK-positive and TK-
negative cells by a minimal dilution procedure described in 
Section 2. Single-cell PCR analyses were performed to detect 
Y-chromosome sequences and the fetal sex was later con-
firmed by ultrasound. As shown in Table 1 we never detected 
Y-sequences in 46 TK-negative cells, whereas all 15 TK-pos-
itive cells analysed contained Y-chromosome DNA. We con-
cluded that the Y-chromosome DNA was specific for the TK-
positive cells, which proves them to be of fetal origin. 
4. Discussion 
The discovery of fetal cells in the circulation of pregnant 
women has been a stimulus for the development of technolo-
gies to detect and enrich these cells in order to use them for 
non(less)-invasive prenatal diagnosis. However, despite some 
initial promising results, the reproducibility and reliability of 
these techniques are still limited, mainly due to the lack of 
very specific markers for fetal cells [2-7]. We describe TK 
activity to be a new specific marker for fetal cells in the ma-
ternal circulation. We further report the successful application 
of a recently established cytofiuorometric TK assay to visual-
ize a very small cell population of high TK activity in the 
excess of TK-negative adult cells. These TK-positive cells in 
the maternal blood can be concluded to be of fetal origin for 
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the following reasons. (1) It has been demonstrated that cir-
culating cells of fetal origin include trophoblasts, fetal lym-
phocytes, nucleated red blood cells and hematopoetic stem 
cells [3]. We showed that trophoblasts and fetal cord blood 
cells express high intracellular levels of TK activity, whereas 
normal adult peripheral blood is totally TK-negative (this 
study and [17]). (2) The small cell population with high TK 
activity specifically occurs in peripheral blood samples of 
pregnant women and not in the circulation of non-pregnant 
individuals. (3) The observed ratio of TK-positive cells in the 
blood of pregnant women (between 1:500000 and 
1:1 000 000) is very comparable to the earlier reported fetal/ 
maternal cell ratio (between 1:475000 and 1:1600000), esti-
mated by other methods [8,9]. (4) By single-cell PCR analyses 
we demonstrated that TK-positive cells in blood of women 
pregnant with a male fetus contain Y-chromosome DNA, 
whereas TK-negative blood cells do not. We did not observe 
higher success rates of the single cell PCR in fetal male cells 
than in maternal female cells as shown by co-amplification 
with control oligonucleotides specific for the oncogene 
HERS. 
One question still remained. Do fetal cells in the maternal 
circulation express the normally S-phase regulated TK activity 
because they still divide or do they exhibit deregulated TK? 
We favour the latter explanation, since it has earlier been 
shown that fetal cells in maternal blood are not responsive 
to mitogens [18]. Proliferation of fetal cells in maternal blood 
is probably down-regulated because these additional cell divi-
sions would seem disadvantageous for these cells and for the 
maternal circulation. In addition, from preliminary data 
showing that fetal cells exhibit a totally deregulated TK ac-
tivity (G. Graf, M. Hengstschlager and E. Wawra, unpub-
lished observation), one could imagine these circulating fetal 
cells to express TK activity independently from S-phase. 
Experiments to enrich fetal cells by fluorescence-activated 
cell sorting with the marker described here are planned in our 
laboratory. Our data provide evidence that fetal cells express 
TK activity constitutively throughout much of the pregnancy. 
However, detailed analyses will have to be performed to test 
whether there are peaks of TK expression, which would be 
perfectly suited for routine application of this approach. 
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